PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)



Status:Recruiting
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 80
Updated:3/23/2019
Start Date:August 1, 2018
End Date:August 2019
Contact:Michael T Nelson, BA
Email:mike.nelson@complexarx.com
Phone:484-329-8430

Use our guide to learn which trials are right for you!

Phase 2 Multicenter, Double-Blind, Placebo Controlled, Efficacy, Safety, and Pharmacokinetic Study of 2 Doses of CXA-10 on Stable Background Therapy in Subjects With Pulmonary Arterial Hypertension

This is a multicenter double-blind, placebo-controlled study to evaluate the safety, efficacy
and pharmacokinetics of 2 doses of CXA-10 on stable background therapy in 96 subjects 18 to
80 years of age with PAH.

This is a multicenter double-blind, placebo-controlled study to evaluate the safety, efficacy
and pharmacokinetics of 2 doses of CXA-10 on stable background therapy in 96 subjects 18 to
80 years of age with PAH.

The study will be performed in approximately 45 study centers across the United States of
America and Europe. The recruitment period is anticipated to be approximately 12 months.
Approximately 115 subjects will be enrolled to ensure at least 96 subjects complete the
study.

Study participation for each subject will last approximately 5 months. The study will consist
of a screening period (within 30 days prior to dosing), 90 day (approximately 3 months)
treatment period and approximately 14 days follow-up period after the end of treatment visit.

Inclusion Criteria:

- Males and females between 18 to 80 years of age inclusive at Screening

- Weight ≥40 kg

- Must have a diagnosis of WHO Group 1 PH

- Have a World Health Organization (WHO) Classification of Functional Status Class II or
III of patients with PH

- Must meet hemodynamic criteria by means of a right heart catheterization

- Meet pulmonary function test parameters

- A 6 MWD test of ≥125m and ≤550m at the visit

- Subjects must have a resting arterial oxygen saturation (SaO2) ≥90%, with or without
supplemental oxygen, as measured by pulse oximetry at Screening

- Subjects enrolled in a prescribed exercise program for pulmonary rehabilitation must
be in a stable program for 3 months prior to Screening (Visit 1) and must agree to
maintain their current level of rehabilitation throughout the study. If subjects are
not enrolled in a prescribed exercise training program for pulmonary rehabilitation,
they cannot enroll during the Screening/Baseline Period or throughout the study

- If receiving simvastatin-containing products: dose should not exceed 20 mg/day

- Subjects must be receiving no more than two of the following previously approved PAH
therapies: phosphodiesterase type 5 (PDE-5) inhibitors, endothelin receptor antagonist
(ERA), soluble guanylate cyclase (sGC) stimulator, prostanoids, prostacyclin receptor
agonists and must be on stable doses (≥3 months) at Screening (Visit 1)

Exclusion Criteria:

- Contraindications for CMRI imaging

- WHO Groups 2, 3, 4 and 5 Pulmonary Hypertension

- Unrepaired congenital heart defects and significant congenital heart defects (i.e.,
atrial septal defects, ventricular septal defects, and patent ductus arteriosus)
repaired less than 1 year prior to Screening (Visit 1) (Group 1 classification of
Pulmonary Hypertension)

- QTcF > 500 msec

- Acute myocardial infarction or acute coronary syndrome within the last 90 days

- Cerebrovascular accident/transient ischemic attack (CVA/TIA) within the last 90 days

- Hospitalization for left heart failure within the last 90 days

- Clinically significant aortic or mitral valve disease defined as greater than mild
regurgitation or mild stenosis; pericardial constriction; restrictive or constrictive
cardiomyopathy; left ventricular dysfunction (LVEF < 50%); left ventricular outflow
obstruction; symptomatic coronary artery disease; autonomic hypotension; or fluid
depletion

- Atrial fibrillation and life-threatening cardiac arrhythmias

- Personal or family history of congenital prolonged QTc syndrome or sudden or sudden
unexpected death due to a cardiac reason

- Clinically significant anemia

- Severe hepatic impairment or active chronic hepatitis

- Receiving intravenous inotropes within 2 weeks prior to Screening

- History of angina pectoris or other condition that was treated with long or short
acting nitrates <12 weeks of Screening

- Subject has taken immunosuppressant therapy < 12 weeks prior to Screening

- Recent (within 1 year) history of abusing alcohol or illicit drugs.

- History of any primary malignancy, with no evidence of disease for at least 5 years

- Treatment with any investigational drug or device within 30 days or 5 half-lives
We found this trial at
26
sites
425 University Blvd.
Indianapolis, Indiana 46202
(317) 274-4591
Indiana University INDIANA UNIVERSITY is a major multi-campus public research institution, grounded in the liberal...
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Durham, North Carolina 27710
(919) 684-8111
Duke University Younger than most other prestigious U.S. research universities, Duke University consistently ranks among...
?
mi
from
Durham, NC
Click here to add this to my saved trials
Miami, Florida 33124
(305) 284-2211
University of Miami A private research university with more than 15,000 students from around the...
?
mi
from
Miami, FL
Click here to add this to my saved trials
6161 Kempsville Circle
Norfolk, Virginia 23502
(757) 261-4986
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
4200 Fifth Ave
Pittsburgh, Pennsylvania 15260
(412) 624-4141
Phone: 412-647-2791
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
12605 East 16th Avenue
Aurora, Colorado 80045
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Birmingham, Alabama 35294
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Charlottesville, Virginia 22908
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
3805 Edwards Road
Cincinnati, Ohio 45129
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
281 W. Lane Ave
Columbus, Ohio 43210
(614) 292-6446
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Dallas, Texas 75390
?
mi
from
Dallas, TX
Click here to add this to my saved trials
1400 Jackson St
Denver, Colorado 80206
(303) 388-4461
National Jewish Health National Jewish Health is known worldwide for treatment of patients with respiratory,...
?
mi
from
Denver, CO
Click here to add this to my saved trials
El Paso, Texas 79905
?
mi
from
El Paso, TX
Click here to add this to my saved trials
Falls Church, Virginia 22042
?
mi
from
Falls Church, VA
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
9500 Gilman Dr
La Jolla, California 92093
(858) 534-2230
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
New York, New York 10016
?
mi
from
New York, NY
Click here to add this to my saved trials
3451 Walnut St
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
320 E North Ave
Pittsburgh, Pennsylvania 15212
(412) 359-3131
Allegheny General Hospital At Allegheny General Hospital, our physicians and healthcare staff have earned an...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Tucson, Arizona 85721
(520) 621-2211
University of Arizona The University of Arizona is a premier, public research university. Established in...
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
Washington, District of Columbia 20010
?
mi
from
Washington,
Click here to add this to my saved trials